Literature DB >> 22683146

[Central nervous system vasculitides: an update].

A Néel1, C Pagnoux, L Guillevin, M Hamidou.   

Abstract

Central nervous system (CNS) vasculitides are a heterogeneous group of diseases that can lead to severe disability and death. Given the poor performance of available diagnostic procedures (magnetic resonance imaging, angiography and brain biopsy), the diagnosis of isolated CNS vasculitis is challenging. Differential diagnosis includes secondary CNS vasculitides (infection, cancer, drug exposure or systemic inflammatory disorders) and several non-inflammatory cerebral vasculopathies, such as the reversible cerebral vasoconstriction syndrome. Despite recent advances in neuroradiology and the publication of large retrospective case series, primary angiitis of the CNS remains a heterogeneous and challenging nosological entity. Prospective interdisciplinary studies are necessary to improve our approach to these patients.
Copyright © 2011 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22683146     DOI: 10.1016/j.revmed.2011.11.020

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.

Authors:  Olga Vera-Lastra; Jesús Sepúlveda-Delgado; María del Pilar Cruz-Domínguez; Gabriela Medina; Moisés Casarrubias-Ramírez; Luis E Molina-Carrión; Luis F Pineda-Galindo; Arturo Olvera-Acevedo; Claudia Hernández-Gonzalez; Luis J Jara
Journal:  Clin Rheumatol       Date:  2014-11-27       Impact factor: 2.980

2.  Commentary.

Authors:  Apostolos Safouris
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

3.  Diagnostic value of HR-MRI and DCE-MRI in unilateral middle cerebral artery inflammatory stenosis.

Authors:  Guo-Chang Wang; Yu-Jing Chen; Xu-Ran Feng; Ping-Yong Feng
Journal:  Brain Behav       Date:  2020-08-07       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.